Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis?

被引：0
|
作者：
Philip N Sambrook
机构：
[1] Philip N Sambrook PN Sambrook is a Professor of Rheumatology at the Kolling Institute,
[2] University of Sydney,undefined
[3] Sydney,undefined
[4] Australia.,undefined
来源：
Nature Clinical Practice Endocrinology & Metabolism | 2007年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：206 / 207
页数：1
相关论文
共 50 条
  • [1] Are bisphosphonates more effective than vitamin D3 analogs for the prevention of glucocorticoid-induced osteoporosis?
    Sambrook, Philip N.
    NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (03): : 206 - 207
  • [2] Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis
    Blair, MM
    Carson, DS
    Barrington, R
    JOURNAL OF FAMILY PRACTICE, 2000, 49 (09) : 839 - 848
  • [3] Bisphosphonates in the prevention and treatment of glucocorticoid-induced osteoporosis
    Roux, C
    Dougados, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (05) : S49 - S52
  • [4] Calcium and vitamin D in the prevention and treatment of glucocorticoid-induced osteoporosis
    Ringe, JD
    Faber, H
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2000, 18 (05) : S44 - S48
  • [5] Vitamin D and Glucocorticoid-Induced Osteoporosis
    Mazziotti, G.
    Formenti, A. M.
    Frara, S.
    Doga, M.
    Giustina, A.
    VITAMIN D IN CLINICAL MEDICINE, 2018, 50 : 149 - 160
  • [6] Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis
    Doga, M
    Bonadonna, S
    Burattin, A
    Carpinteri, R
    Manelli, F
    Giustina, A
    GLUCOCORTICOID-INDUCED OSTEOPOROSIS, 2002, 30 : 150 - 164
  • [7] Bisphosphonates and glucocorticoid-induced osteoporosis: cons
    Willem F. Lems
    Kenneth Saag
    Endocrine, 2015, 49 : 628 - 634
  • [8] Alendronate is more effective than alphacalcidol in preventing glucocorticoid-induced osteoporosis.
    de Nijs, R
    Jacobs, J
    Algra, A
    Buskens, E
    Huisman, A
    Laan, R
    de Laet, C
    Lems, W
    Bijlsma, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S442 - S443
  • [9] Bisphosphonates and glucocorticoid-induced osteoporosis: cons
    Lems, Willem F.
    Saag, Kenneth
    ENDOCRINE, 2015, 49 (03) : 628 - 634
  • [10] Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros
    Rossini, Maurizio
    Orsolini, Giovanni
    Viapiana, Ombretta
    Adami, Silvano
    Gatti, Davide
    ENDOCRINE, 2015, 49 (03) : 620 - 627
12345